MCT and Omega-3 Pet Food for Struvite Urolithiasis

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Existing treatments for inflammatory disorders in animals, such as inflammatory bowel disease, are ineffective and can have harmful side effects, and there is a need for alternative methods to manage inflammation and dysbiosis in companion animals.

Innovation Solution

Pet food compositions containing medium chain triglycerides (MCTs) and omega-3 fatty acids, specifically caprylic acid, capric acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA), which synergistically decrease circulating cytokines and increase carnitine levels, thereby reducing inflammation and improving metabolic health.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional treatments (steroids) are used to fight inflammation, then inflammatory chemicals production is reduced, but considerable side effects occur and the condition may worsen

Engineering Contradiction:

Improveinflammation treatment effectivenessVSAvoidside effects

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces long-term steroid treatment with a natural dietary composition containing medium chain triglycerides and omega-3 fatty acids. This composition acts as a short-term, natural intervention that reduces proinflammatory cytokines without the cumulative side effects of steroids, allowing the animal's own immune system to regulate inflammation naturally

Inventive Principle:

Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent changes the approach from pharmacological suppression (steroids) to nutritional modulation by incorporating specific fatty acids (medium chain triglycerides and omega-3) into the diet. This parameter change shifts the treatment mechanism from direct anti-inflammatory action to modulating the body's inflammatory response through metabolic pathways

Inventive Principle:

Principle #35Parameter changes

2Productivity

If steroids are frequently prescribed to manage inflammation, then inflammatory response is suppressed, but the drug becomes abused and causes harm

Engineering Contradiction:

Improveinflammation management efficiencyVSAvoiddrug abuse and harm

Core Design Contradiction:

ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent enables the animal's body to self-regulate inflammation through nutritional support rather than external drug intervention. The medium chain triglycerides and omega-3 fatty acids provide the building blocks for the body to naturally modulate cytokine production and inflammatory responses, reducing dependence on prescription drugs

Inventive Principle:

Principle #25Self-service

3Reliability

If dysbiosis is present in the gastrointestinal tract, then bacterial imbalance occurs, but proinflammatory substances are produced causing tissue damage

Engineering Contradiction:

Improvegastrointestinal healthVSAvoidproinflammatory substances

Core Design Contradiction:

ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful effect of dysbiosis-induced proinflammatory cytokine production into a beneficial outcome by using medium chain triglycerides and omega-3 fatty acids to modulate the immune response. These fatty acids don't eliminate the dysbiosis but transform its harmful inflammatory output into a controlled, reduced cytokine response that protects tissues while maintaining immune surveillance

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS12458617B2Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis

Publication Date: 2025.11.04 HILLS PET NUTRITION INC

AI summary

Disclosed herein are pet food compositions for treating or preventing—inter alia—struvite urolithiasis comprising at N least one of caprylic acid and capric acid; and at least one of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).